Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.00
Bid: 0.95
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.10 (10.526%)
Open: 1.00
High: 1.00
Low: 1.00
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition, Update & Change of Registered Office

12 Jan 2024 16:15

RNS Number : 5915Z
Microsaic Systems plc
12 January 2024
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain. Investors who have participated in a market sounding exercise in relation to the Placing will have received additional inside information in relation to the Placing and will be cleansed on that inside information upon announcement of the Placing, at which point additional disclosures will be released to the market, prior to the planned restoration of the Company's New Ordinary Shares to trading on AIM and Admission of the Placing Shares.

 

 

12 January 2024

Microsaic Systems plc

("Microsaic" or the "Company")

 

Acquisition, Update & Change of Registered Office

 

Capitalised terms in this announcement carry the same meaning as in the Circularor subsequent announcements, unless the context indicates otherwise

 

Microsaic Systems plc (AIM: MSYS), the developer of micro-electronic instruments and analytical solutions, announces that its due diligence in connection with the purchase of certain assets of the Modern Water business previously operated by DeepVerge and certain of its subsidiary companies (the "Assets") has now concluded and the Acquisition Agreement has been entered into with DeepVerge. The Company also provides an update below on the expected timing for concluding firm commitments on the Placing, the publication of the Annual Report and Interim Results, Restoration and Admission.

 

Acquisition

 

The Company has today executed and exchanged the Acquisition Agreement with DeepVerge plc and Innovenn UK Limited to acquire certain Assets for a total consideration of £100,000 ("Acquisition"), at completion ("Completion").

 

The Assets comprise the trade and all equipment used by the Modern Water business relating to the manufacturing of the Microtox® bio-reagents, related trade names, intellectual property, design and all manufacturing rights for water testing equipment using Microtox® bio-reagent as a consumable known as the FX, LX and Continuous Toxic Measurement (CTM) machines.

 

Completion is subject to various conditions including admission to trading on AIM ("Admission") of the placing shares to be issued by way of a placing arranged by TPI ("Placing Shares") and the delivery of several intellectual property assignments by no later than 24 January 2024. At Completion the assets will be transferred to the Company and the consideration of £100,000 paid to the sellers.

 

Completion of the Acquisition is expected to become effective by no later than 24 January 2024, following Restoration (the restoration to trading on AIM of the Company's New Ordinary Shares following the Capital Reorganisation) and Admission, both of which are expected on Tuesday 16 January, 2023.

 

A further announcement will be made once Completion of the Acquisition has occurred.

 

Related Party Transaction

 

As previously announced, Dr Nigel Burton, Non-executive Director of the Company, is also a director of DeepVerge and therefore the Acquisition constitutes a related party transaction for the Company pursuant to Rule 13 of the AIM Rules. Bob Moore being the independent director of the Company for the purposes of negotiating and concluding the Acquisition and the requirements of AIM Rule 13, having consulted with Singer Capital Markets Advisory LLP as the Company's nominated adviser, considers the terms of the Acquisition to be fair and reasonable insofar as the Company's shareholders are concerned.

 

Revised Fundraising

 

As previously announced on 4 January 2024, the Company is finalising binding commitments for the Revised Fundraising, being executed by way of the Placing arranged via TPI, and expects to confirm no later than Monday 15 January that it has obtained conditional funding in excess of the revised minimum amount needed for the Acquisition consideration and for the working capital purposes of the enlarged business.

 

Publication of Annual Report & Interim Results

 

Completion of the Revised Fundraising remains conditional upon, inter alia, the publication of both the Annual Report and the Interim Results, in order to be compliant with the requirements of the AIM Rules for Companies in terms of financial reporting. The Company expects to publish the Annual Report & Interims Results after 5.00 p.m. on Monday 15 January, 2024.

 

Restoration and Admission

 

Assuming completion of the above items, inter alia, the Company intends to seek restoration of its New Ordinary Shares to trading on AIM with effect from 7.30 a.m. on Tuesday 16 January, 2024 and has applied for Admission of the Placing Shares to trading on AIM with effect from 8.00 a.m. on Tuesday 16 January 2024.

 

In the event that the Company is unable to proceed with Revised Fundraising or otherwise satisfy any of the necessary prior conditions for Restoration and Admission, then admission of the Company's shares to trading on AIM would be cancelled and a further announcement made in that regard.

 

Change of Registered Office

 

Microsaic Systems plc announces that the registered office of the Company has been changed to 1-5 Park Road, Caterham, Surrey, CR3 5TB.

 

 

Enquiries:

Microsaic Systems plc

Bob Moore, Acting Executive Chairman

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets(Nominated Adviser & Joint Broker)

Aubrey Powell / Angus Campbell / Oliver Platts

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic Systems

Microsaic has over 20 years' experience in microelectronics and development of instrumentation. The Company has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application serving markets in diversified Industries, Human and Environmental Health. Microsaic's system solutions have enabled analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps in the process workflow.

 

Microsaic's products and solutions are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications.

 

Indicative Timetable of Principal Events

 

Event

 

Time and/or date ?¹?

Latest date and time by which entry into the conditional Placing commitments needs to announced for the Restoration and Admission to occur as indicated below

Prior to 3.30 p.m. on15 January 2024

Publication of the Report and Accounts and Interim Results, and notification of the same

After 5.00 p.m. on15 January 2024

 

Restoration of New Ordinary Shares to trading on AIM

 

 

7.30 a.m. on16 January 2024

 

Admission of the shares pursuant to the Revised Fundraising to trading on AIM

 

8.00 a.m. on16 January 2024

Completion of the Acquisition

within 5 business days of this announcement

 

Latest date for share certificates overNew Ordinary Shares to be dispatched(where applicable)

 

 

Within 10 days ofRestoration andAdmission

 

Note:

?¹? All of the times referred to in this announcement refer to London time, unless otherwise stated, and are subject to change. In the event that any key item takes longer to occur, Restoration and Admission may move to a later date, in which case a further announcement would be made.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBUGDBCUBDGSD
Date   Source Headline
11th Aug 20209:30 amRNSForm 8.5 (EPT/RI)
10th Aug 20204:33 pmBUSForm 8.3 - Microsaic Systems
10th Aug 202010:08 amRNSForm 8.5 (EPT/RI)
7th Aug 20204:59 pmRNSForm 8.3 - Microsaic Systems PLC
7th Aug 20209:14 amRNSForm 8.5 (EPT/RI)
6th Aug 202012:07 pmRNSForm 8.5 (EPT/RI)
5th Aug 202010:04 amRNSForm 8.5 (EPT/RI)
4th Aug 20202:31 pmRNSForm 8.3 - Microsaic Systems PLC
4th Aug 202011:39 amRNSForm 8.5 (EPT/RI)
3rd Aug 20201:54 pmRNSForm 8.3 - Microsaic Systems plc
3rd Aug 202011:24 amRNSForm 8.5 (EPT/RI)
31st Jul 20204:06 pmRNSForm 8 (OPD) Microsaic Systems plc
31st Jul 20201:43 pmRNSForm 8.3 - Microsaic Systems plc
31st Jul 20209:37 amRNSForm 8.5 (EPT/RI)
31st Jul 20209:11 amRNSForm 8.3 - Microsaic Systems plc
30th Jul 20204:03 pmRNSParkwalk Advisors: Form 8.3- Microsaic Systems plc
30th Jul 202011:47 amRNSForm 8.5 (EPT/RI)
29th Jul 20205:48 pmGNWForm 8.3 - Microsaic Systems plc
29th Jul 202012:00 pmRNSForm 8.3 - Microsaic Systems plc
29th Jul 20207:00 amRNSStrategic Review and Formal Sale Process
25th Jun 20203:16 pmRNSResult of AGM
1st Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20207:00 amRNSCOVID-19 Update
9th Mar 20207:00 amRNSFinal Results
3rd Mar 20207:00 amRNSAppointment of WH Ireland as Joint Broker
26th Feb 20207:00 amRNSGlobal collaboration agreement with Axcend Corp
16th Jan 20207:00 amRNSPre-close Trading Update
16th Dec 20197:00 amRNSMicrosaic collaborates with the CPI
6th Dec 20194:35 pmRNSPrice Monitoring Extension
5th Dec 20199:05 amRNSSecond Price Monitoring Extn
5th Dec 20199:00 amRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSExclusive Japan Distribution Agreement
13th Nov 20194:41 pmRNSSecond Price Monitoring Extn
13th Nov 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.